Stocksigma LogoStocksigma Logo

Vineet Laboratories Reports Zero Deviation in Rights Issue Fund Utilization

Vineet Laboratories confirmed no deviation or variation in utilizing proceeds from its ₹2,996.81 Lakhs equity rights issue for the quarter ended 30th

Vineet Laboratories Reports Zero Deviation in Rights Issue Fund Utilization

Vineet Laboratories Ltd · Others (Uncategorized) · 27 Oct 2026, 12:36 am

Vineet Laboratories Reports Zero Deviation in Rights Issue Fund Utilization Vineet Laboratories confirmed no deviation or variation in utilizing proceeds from its ₹2,996.81 Lakhs equity rights issue for the quarter ended 30th Jun'26. Monitored by Crisil Ratings, the company fully deployed ₹284 Lakhs toward bank loan repayments and utilized ₹670.66 Lakhs of the allocated ₹670.83 Lakhs for general corporate purposes. Additionally, ₹33.75 Lakhs has been spent toward the ₹270 Lakhs effluent treatment plant project, and ₹293.65 Lakhs has been invested out of ₹1,695.35 Lakhs allocated for setting up new production facilities.

Original exchange filing (PDF)

More announcements from Vineet Laboratories Ltd

All Vineet Laboratories Ltd announcements